What is new in the 2020 British guidelines for cutaneous squamous cell carcinoma?

U Leiter¹

Affiliations

Comment

U Leiter. Br J Dermatol. 2021 Mar.

. 2021 Mar;184(3):384-385.

doi: 10.1111/bjd.19861.

U Leiter¹

¹ Center of Dermato-oncology, Department of Dermatology, University of Tübingen, Liebermeisterstraβe 25, Tübingen, 72076, Germany.

No abstract available

Comment on

British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020.
Keohane SG, Botting J, Budny PG, Dolan OM, Fife K, Harwood CA, Mallipeddi R, Marsden JR, Motley RJ, Newlands C, Proby C, Rembielak A, Slater DN, Smithson JA, Buckley P, Fairbrother P, Hashme M, Mohd Mustapa MF, Exton LS; British Association of Dermatologists’ Clinical Standards Unit. Keohane SG, et al. Br J Dermatol. 2021 Mar;184(3):401-414. doi: 10.1111/bjd.19621. Epub 2021 Jan 18. Br J Dermatol. 2021. PMID: 33150585 No abstract available.

1. Eigentler TK, Leiter U, Hafner HM et al. Survival of patients with cutaneous squamous cell carcinoma: results of a prospective cohort study. J Invest Dermatol 2017; 137:2309-15.
1. Leiter U, Keim U, Eigentler T et al. Incidence, mortality, and trends of nonmelanoma skin cancer in Germany. J Invest Dermatol 2017; 137:1860-7.
1. Keohane SG, Botting J, Budny PG et al. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. Br J Dermatol 2021; https://doi.org/10.1111/bjd.19621.
1. Brouwers MC, Kho ME, Browman GP et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182:E839-E842.
1. Jambusaria-Pahlajani A, Kanetsky PA, Karia PS et al. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol 2013; 149:402-10.